Diabetes Research and Clinical Practice
Volume 62, Issue 1 , Pages 9-16 , October 2003

Subjective health values of individuals with diabetes in Japan: comparison of utility values with the SF-36 scores

  • Isao Ohsawa

      Affiliations

    • Research Center of Health, Physical Fitness and Sports, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-52-789-3967; fax: +81-52-789-5242
    • ,
  • Taemi Ishida

      Affiliations

    • College of Life and Environment Science, Tokai Gakuen University, Tenpaku-ku, Nagoya 468-8514, Japan
    • ,
  • Yoshiharu Oshida

      Affiliations

    • Research Center of Health, Physical Fitness and Sports, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
    • ,
  • Kunio Yamanouchi

      Affiliations

    • Department of Internal Medicine, Division of Endocrinology, Metabolism and Diabetology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan
    • ,
  • Yuzo Sato

      Affiliations

    • Research Center of Health, Physical Fitness and Sports, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan

Received 25 February 2003 ,Revised 20 May 2003 ,Accepted 9 June 2003.

References 

  1. Sox HC, Blatt MA, Higgins MC, Marton KI. Decision making when the outcomes have several dimensions. In: Medical Decision Making. Boston, MA: Butterworths-Heinemann; 1988;p. 201–237
  2. Weinstein MC, Fineberg HV. Utility analysis: Clinical decisions involving many possible outcomes. In: Clinical Decision Analysis. Philadelphia, PA: WB Saunders Company; 1980;p. 184–227
  3. Froberg DG, Kane RL. Methodology for measuring health-state preferences: II. Scaling methods. J. Clin. Epidemiol. 1989;42:459–471
  4. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Cost-utility analysis. In: Methods for the Economic Evaluation of Health Care Programmes. second ed.. New York, NY: Oxford University Press; 1997;p. 139–204
  5. Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the management of preferences for health states?. Med. Decis. Making. 2001;21:329–334
  6. Ohsawa I, Ishida T, Mori K, et al.  Subjective valuation for the quality of life in individuals with diabetes mellitus by utility assessment. J. Jap. Diab. Soc. 1999;42:341–346
  7. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. J. Am. Med. Assoc. 1994;272:619–626
  8. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann. Intern. Med. 1993;118:622–629
  9. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute; 1993;
  10. Riegelman RK. Assessment. In: Studying a Study and Testing a Test. How to Read the Health Science Literature. fourth ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2000;p. 235–239
  11. von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. New York, NY: Wiley; 1953;
  12. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey use in Japan. J. Clin. Epidemiol. 1998;51:1037–1044
  13. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J. Clin. Epidemiol. 1998;51:1045–1053
  14. Fukuhara S, Suzukamo Y, Kurokawa K. Manual of SF-36 Japanese version 1.2. Tokyo: Public Health Research Center; 2001;
  15. Read JL, Quinn R, Berwick D, Finberg H, Weinstein M. Preferences for health outcomes: comparison of assessment methods. Med. Decis. Making. 1984;4:315–329
  16. Ahroni JH, Davignon DR, Boyko EJ, Pecoraro RE. The health and functional status of veterans with diabetes. Diabetes Care. 1994;17:318–321
  17. Gulliford MC, Mahabir D. Relationship of health-related quality of life to symptom severity in diabetes mellitus: a study in Trinidad and Tobago. J. Clin. Epidemiol. 1999;52:773–780
  18. Klein BEK, Klein R, Moss SE. Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1998;21:236–240
  19. Nerenz DR, Repasky DP, Whitehouse FW, Kahkonen DM. Ongoing assessment of health status in patients with diabetes mellitus. Med. Care. 1992;30(Suppl. 5):MS112–MS124
  20. Weinberger M, Kirkman MS, Samsa GP, et al.  The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med. Care. 1994;32:1173–1181
  21. Anderson RM, Davis WK, Fitzgerald JT, Hiss RG, Wisdom K. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care. 1997;20:299–305
  22. Jacobson AM, Samson JA, De Groot M. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994;17:267–274
  23. Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P. Quality of life associated with diabetes mellitus in an adult population. J. Diabetes Complicat. 2000;14:18–24
  24. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am. J. Ophthalmol. 1999;128:324–330
  25. Douzdjian V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetes with ESRD: a cost-effectiveness decision analysis model. Am. J. Kidney Dis. 1998;31:794–802
  26. UK Prospective Diabetes Study Group, Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37), Diabetes Care 22 (1999) 1125–1136.
  27. Clark P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med. Decis. Making. 2002;22:340–349

PII: S0168-8227(03)00145-1

doi: 10.1016/S0168-8227(03)00145-1

Diabetes Research and Clinical Practice
Volume 62, Issue 1 , Pages 9-16 , October 2003

Article Tools

* Image Usage & Resolution